QP2-TZ 60mg
Dual incretin-receptor agonist studied in metabolic and glycemic research.
This is the larger-format QP2-TZ vial: 60 mg of the same dual incretin-receptor agonist offered in the 30 mg size, intended for laboratories running extended assay series or several experimental arms from a single stock. Working from one vial keeps reconstitution conditions consistent across a project.
Chemically, QP2-TZ is a 39-residue peptide acylated with a C20 fatty diacid on lysine 20, a modification that drives reversible albumin binding. Its two Aib substitutions resist dipeptidyl peptidase-4 cleavage. In receptor pharmacology it is notable for an imbalanced profile: published characterizations describe activity at one incretin receptor comparable to the native hormone and signaling at the other that favors cAMP generation over beta-arrestin recruitment. That asymmetry makes it a useful comparator against single-receptor and triple-agonist compounds.
A third-party certificate for this product is coming soon. For laboratory research use only.
Research areas: Incretin receptor pharmacology, cAMP versus beta-arrestin signaling, Comparative incretin studies, Long-acting peptide design.
Technical data
- Formula
- C225H348N48O68
- Molecular weight
- 4813 g/mol
- CAS
- 2023788-19-2
- PubChem CID
- 166567236
Category: Metabolic. Price: $125.00 USD. COA coming soon.
All products are sold strictly for in-vitro laboratory research. Not for human or veterinary use. Not drugs or supplements.